Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Nov 6, 2019 · 10-Q · 37 days after period end · 0001564590-19-040673
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$3.67M | -$3.24M | -$6.47M | -$268.00K |
| EPS Diluted | -$9.07 | -$0.71 | -$8.95 | -$12.62 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 6, 2019 · 37 d after period end
